Allianz Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,100
Closed -$677K 2406
2024
Q4
$677K Buy
8,100
+3,100
+62% +$255K ﹤0.01% 1765
2024
Q3
$366K Buy
+5,000
New +$376K ﹤0.01% 1939
2022
Q3
Sell
-12,450
Closed -$711K 2173
2022
Q2
$711K Hold
12,450
﹤0.01% 1792
2022
Q1
$762K Hold
12,450
﹤0.01% 1982
2021
Q4
$652K Hold
12,450
﹤0.01% 2097
2021
Q3
$464K Sell
12,450
-5,800
-32% -$202K ﹤0.01% 2261
2021
Q2
$745K Sell
18,250
-12,635
-41% -$467K ﹤0.01% 1867
2021
Q1
$1.05M Hold
30,885
﹤0.01% 1623
2020
Q4
$982K Hold
30,885
﹤0.01% 1484
2020
Q3
$793K Buy
30,885
+13,226
+75% +$302K ﹤0.01% 1495
2020
Q2
$454K Sell
17,659
-18,172
-51% -$368K ﹤0.01% 2085
2020
Q1
$551K Buy
35,831
+7,309
+26% +$159K ﹤0.01% 2020
2019
Q4
$979K Sell
28,522
-9,042
-24% -$109K ﹤0.01% 2206
2019
Q3
$281K Buy
37,564
+17,544
+88% +$168K ﹤0.01% 2542
2019
Q2
$260K Buy
+20,020
New +$257K ﹤0.01% 2538
2016
Q2
Sell
-39,452
Closed -$1.1M 2638
2016
Q1
$1.1M Sell
39,452
-123,884
-76% -$4.13M ﹤0.01% 2042
2015
Q4
$8.79M Sell
163,336
-28,902
-15% -$1.46M 0.01% 1115
2015
Q3
$7.7M Buy
+192,238
New +$6.27M 0.01% 1093

Other funds holding ITCI